Literature DB >> 26725178

A Prospective Clinical Pilot Study on the Level of Matrix Metalloproteinase-9 in Dental Pulpal Blood as a Marker for the State of Inflammation in the Pulp Tissue.

Johannes Mente1, Jelena Petrovic2, Holger Gehrig2, Sarah Rampf2, Annemarie Michel2, Alexander Schürz2, Thorsten Pfefferle2, Daniel Saure3, Ralf Erber4.   

Abstract

INTRODUCTION: Differentiation between reversible pulpitis (savable pulp) and irreversible inflammation of the pulp tissue (nonsavable pulp) based only on clinical and radiographic diagnoses has proven to be difficult. Pulp exposure allows for the collection of pulpal blood to quantitatively determine the level of inflammation markers or proteolytic enzymes, even with small samples. Pulpitis is associated with the invasion of neutrophil granulocytes and their release of matrix metalloproteinase-9 (MMP-9).
METHODS: Forty-four patients (aged 18-74 years, mean = 35 years), each with 1 tooth with carious pulp exposure presenting with different stages of pulpitis, were included in this prospective, 2-center clinical study; 26 patients presented with irreversible pulpitis (groups 3 and 4), 10 with reversible pulpitis (group 2), and 8 with completely asymptomatic teeth with deep carious lesions (group 1). Six of the 26 patients with teeth diagnosed with irreversible pulpitis had not taken any nonsteroidal anti-inflammatory drugs and were evaluated as a separate group (group 4). Partial pulpotomy and blood sample collection from the pulp chamber were performed. The total levels of MMP-9 and tissue inhibitor of metalloproteinase-1 were assessed by fluorometric and colorimetric enzyme-linked immunosorbent assays, respectively. The Mann-Whitney U test and Spearman rank correlations were used to compare the MMP-9 levels with different stages of pulpal inflammation; significance was set at .05.
RESULTS: The MMP-9 levels in the asymptomatic teeth (group 1) were significantly different from those in the teeth with reversible pulpitis (group 2, P = .006) or irreversible pulpitis (group 4, P < .001). A statistically significant difference was also observed between the MMP-9 levels in group 1 and group 3 (P < .001) in which the patients had taken nonsteroidal anti-inflammatory drugs.
CONCLUSIONS: These findings indicate that the MMP-9 levels in pulpal blood samples could be a useful ancillary diagnostic tool for distinguishing different stages of pulp tissue inflammation.
Copyright © 2016 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical diagnosis; irreversible pulpitis; matrix metalloproteinase-9; pulp tissue inflammation; reversible pulpitis

Mesh:

Substances:

Year:  2015        PMID: 26725178     DOI: 10.1016/j.joen.2015.10.020

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  10 in total

1.  Morphological analysis and immunohistochemical expression in restorations with self-adhesive resin: A randomized split-mouth design-controlled study.

Authors:  Natália-Gomes de Oliveira; Marina-Torreão da Silveira; Leorik-Pereira da Silva; Keylla-Marinho-Albuquerque Barros; Laís-Maciel Costa; Marília-de Lima Soares; Marianne-de Vasconcelos Carvalho
Journal:  J Clin Exp Dent       Date:  2021-09-01

Review 2.  Dentine matrix metalloproteinases as potential mediators of dentine regeneration.

Authors:  E Guirado; A George
Journal:  Eur Cell Mater       Date:  2021-11-24       Impact factor: 4.325

Review 3.  Biological Markers for Pulpal Inflammation: A Systematic Review.

Authors:  Dan-Krister Rechenberg; Johnah C Galicia; Ove A Peters
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

Review 4.  Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles.

Authors:  Michaela Kearney; Paul R Cooper; Anthony J Smith; Henry F Duncan
Journal:  Front Genet       Date:  2018-08-07       Impact factor: 4.599

5.  MMP-9 Levels and NaOCl Lavage in Randomized Trial on Direct Pulp Capping.

Authors:  N V Ballal; H F Duncan; D B Wiedemeier; N Rai; P Jalan; V Bhat; V S Belle; M Zehnder
Journal:  J Dent Res       Date:  2021-10-27       Impact factor: 6.116

Review 6.  A critical analysis of research methods to study clinical molecular biomarkers in Endodontic research.

Authors:  Matthias Zehnder; Georgios N Belibasakis
Journal:  Int Endod J       Date:  2021-10-31       Impact factor: 5.165

Review 7.  Present status and future directions-Vital pulp treatment and pulp preservation strategies.

Authors:  Henry F Duncan
Journal:  Int Endod J       Date:  2022-02-03       Impact factor: 5.165

Review 8.  Dentin Matrix Metalloproteinases: A Futuristic Approach Toward Dentin Repair and Regeneration.

Authors:  Paridhi Agrawal; Pradnya Nikhade; Manoj Chandak; Anuja Ikhar; Rushikesh Bhonde
Journal:  Cureus       Date:  2022-08-12

9.  Saliva proteomic patterns in patients with molar incisor hypomineralization.

Authors:  K Bekes; G Mitulović; N Meißner; U Resch; R Gruber
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

10.  Diagnostic biomarker candidates for pulpitis revealed by bioinformatics analysis of merged microarray gene expression datasets.

Authors:  Ming Chen; Junkai Zeng; Yeqing Yang; Buling Wu
Journal:  BMC Oral Health       Date:  2020-10-12       Impact factor: 2.757

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.